Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -38.03% | -23.04% | -21.73% | 259.30% | 156.79% |
| Total Receivables | 337.21% | -49.61% | -85.54% | 119.47% | 671.77% |
| Inventory | -5.31% | -32.03% | 50.98% | 11.95% | 76.72% |
| Prepaid Expenses | 14.61% | -8.22% | 9.31% | 50.43% | 30.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -- | -- | -- | -22.93% |
| Total Current Assets | -28.44% | -20.32% | -25.98% | 208.39% | 145.34% |
|
|
|||||
| Total Current Assets | -28.44% | -20.32% | -25.98% | 208.39% | 145.34% |
| Net Property, Plant & Equipment | 42.59% | -2.79% | -6.74% | 13.14% | -2.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -100.00% | 0.00% | 0.00% | -0.05% | -74.16% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -17.86% | -39.18% | 2.56% | -2.05% | -0.33% |
| Total Assets | -41.38% | -13.03% | -16.31% | 72.06% | -50.04% |
|
|
|||||
| Total Accounts Payable | 140.91% | -17.31% | -43.97% | 38.88% | 88.19% |
| Total Accrued Expenses | 84.71% | 25.56% | -43.49% | 35.42% | 2.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 13.08% | 3.77% | 9.69% | 8.42% | 0.94% |
| Total Finance Division Other Current Liabilities | -59.47% | 53.27% | 59.12% | 89.91% | -92.21% |
| Total Other Current Liabilities | -59.47% | 53.27% | 59.12% | 89.91% | -92.21% |
| Total Current Liabilities | 57.64% | 15.15% | -31.30% | 33.10% | -19.97% |
|
|
|||||
| Total Current Liabilities | 57.64% | 15.15% | -31.30% | 33.10% | -19.97% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.53% | -16.63% | -11.57% | -12.45% | -12.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -1.11% | 7.36% | 6.64% | 1.79% | -22.58% |
| Total Liabilities | 7.69% | 7.52% | -1.44% | 5.89% | -21.73% |
|
|
|||||
| Common Stock & APIC | 0.19% | 0.15% | 0.16% | 8.62% | 3.54% |
| Retained Earnings | -6.08% | -2.96% | -2.73% | -1.90% | -10.57% |
| Treasury Stock & Other | 0.00% | 1.18% | 107.32% | 95.24% | -63.16% |
| Total Common Equity | -242.15% | -937.52% | -89.25% | 183.25% | -226.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -242.15% | -937.52% | -89.25% | 183.25% | -226.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -242.15% | -937.52% | -89.25% | 183.25% | -226.39% |
|
|
|||||